Acute lymphoblastic leukemia. Acute lymphoblastic leukemia [ALL]
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children with acute lymphoblastic leukemia (ALL) who have blood levels of liver enzymes more than 4-2 times normal are included in the study In the consent form, giving the participants the right to choose to participate or not to participate in the research and to keep the information confidential A written consent form from the child or their parents is the moral obligation of the researcher not to impose costs on the patients
Exclusion criteria
Exclusion criteria: In case of hepatitis and liver failure, they will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Level of ALT liver enzymes. Timepoint: The beginning of the study, one and a half months, three and six months after the end of the study. Method of measurement: blood test.;Level of liver enzymes AST. Timepoint: The beginning of the study, one and a half months, three and six months after the end of the study. Method of measurement: blood test.;Serum bilirubin level. Timepoint: The beginning of the study, one and a half months, three and six months after the end of the study. Method of measurement: blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Kermanshah University of Medical Sciences